Back

Efficacy of sodium–glucose cotransporter 2 inhibitors in heart failure patients with low body mass index

28 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Heart failure: integrating therapies and education Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Kei Nakamoto

Osaka Police Hospital, Osaka (Japan)

6 More presentations in this session

Presentation thumbnail
Additive benefits of combination ARNI and SGLT2 inhibitor therapy in real-world heart failure: a propensity-weighted analysis of 11,483 asian patients
Doctor P. Amornritvanich (Bangkok, TH)
Abstract Slides Video
Presentation thumbnail
Low blood pressure and the effect of SGLT2 inhibitors in heart failure with reduced ejection fraction: data from the China Cardiovascular Association Database-Heart Failure Center Registry
Doctor W. Jin (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Hyperkalemia and its outcome implications in patients with heart failure with reduced ejection fraction: results from a single-center cohort
Doctor M. Mantovani (Modena, IT)
Abstract Slides Video
Presentation thumbnail
Outcomes of sacubitril/valsartan plus SGLT2 inhibitors versus SGLT2 inhibitors in heart failure with reduced ejection fraction: a propensity-matched real-world analysis
Doctor O. Alameen (Doha, QA)
Abstract Slides Video
Presentation thumbnail
Systematic review and meta-analysis of GLP-1 receptor agonists in heart failure: impact on 6-minute walk test performance
Doctor T. Christophides (Nicosia, CY)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure: integrating therapies and education

The Event

Event poster

ESC Congress 2026

28 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
SGLT2 inhibitor use in underweight patients with diabetes mellitus and heart failure
17 May 2025
thumbnail
Congress Presentation
Role of SGLT2I in improving right ventricular systolic function in patients with HFpEF
28 August 2026
thumbnail
Congress Presentation
Patients hospitalised due to acute heart failure: baseline characteristics, clinical presentation, echocardiographic data and outcomes among the body mass index categories
20 May 2025
thumbnail
Congress Presentation
Adverse prognostic association of SGLT2 inhibitors in hospitalized heart failure patients with very low body mass index
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources